Weightloss Drugs

Medicare To Cover Eli Lilly's Weight Loss Drug Zepbound For Obstructive Sleep Apnea Treatment

Eli Lilly Joins FDA Lawsuit Over Compounded Obesity Drugs, Seeks 'Swift End' And 'To Protect Its Interests'

US Employer Health Costs To Rise In 2025 Fueled By Weight Loss: Report

Eli Lilly Joins FDA Lawsuit Over Compounded Obesity Drugs, Seeks 'Swift End' And 'To Protect Its Interests'

US Employer Health Costs To Rise In 2025 Fueled By Weight Loss: Report

Eli Lilly's Zepbound Vs. Novo Nordisk's Wegovy - Which Shows Greater Weight Loss?

Wegovy Manufacturer Inks Multi-Million Deal For Monthly Obesity Drug

Eli Lilly's Zepbound Vs. Novo Nordisk's Wegovy - Which Shows Greater Weight Loss?

Wegovy Manufacturer Inks Multi-Million Deal For Monthly Obesity Drug

What's Going With WeightWatchers Stock On Wednesday?

Regeneron Chief Flags Health Risks with Popular Weight-Loss Medications Like Ozempic, Says Company Targets Muscle Preservation For Its Obesity Drugs

Weightloss Drugs Recent News

Eli Lilly Pumps $800M Into Irish Operations To Meet Skyrocketing Demand For Mounjaro, Zepbound

The investment is aimed at ensuring a steady supply of the drugs, which have been grappling with shortages since 2022.

Novo Nordisk Tumbles 3% In Wednesday Premarket: What's Causing 'Miracle' Weight Loss Drug Ozempic Maker's Stock Slide?

The dip in Novo Nordisk's shares comes despite deep-pocketed investors were adopting a bullish approach.

'Not Just A Weight Loss Story:' Eli Lilly CEO Thinks It's Possible To Meet BofA's $60B Revenue Projection From New Drug Launches

Ricks highlighted that the company is trying to prove the efficacy of its drugs for not only weight loss but also obesity-driven diseases such as heart risks, diabetes, and sleep apnea.